In this study, we performed a pan-cancer analysis to look at the effect of SETD2 mutation and depletion in 24 cancer types using The Cancer Genome Atlas (TCGA) data and found that both SETD2 alternative variants and reduced expression are associated with characteristic DNA methylation changes in 21 out of the 24 cancer types tested. This evidence concerns the gene SETD2 and cancer.